Does TROFINETIDE Cause Product dose omission issue? 710 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 710 reports of Product dose omission issue have been filed in association with TROFINETIDE (Daybue). This represents 14.9% of all adverse event reports for TROFINETIDE.
710
Reports of Product dose omission issue with TROFINETIDE
14.9%
of all TROFINETIDE reports
3
Deaths
134
Hospitalizations
How Dangerous Is Product dose omission issue From TROFINETIDE?
Of the 710 reports, 3 (0.4%) resulted in death, 134 (18.9%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TROFINETIDE. However, 710 reports have been filed with the FAERS database.
What Other Side Effects Does TROFINETIDE Cause?
Diarrhoea (2,684)
Underdose (1,540)
Vomiting (870)
Seizure (603)
Constipation (523)
Product use complaint (472)
Weight decreased (433)
Drug ineffective (367)
Decreased appetite (331)
Intentional dose omission (324)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which TROFINETIDE Alternatives Have Lower Product dose omission issue Risk?
TROFINETIDE vs TROFOSFAMIDE
TROFINETIDE vs TROPATEPINE
TROFINETIDE vs TROPICAMIDE
TROFINETIDE vs TROSPIUM
TROFINETIDE vs TROSPIUM\XANOMELINE